Loading…
Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats
Aim: Glycine, one of the non‐essential amino acids, has been reported to be effective in reducing negative symptoms of schizophrenia. Recently, we found that glycine improves subjective sleep quality in humans. The aim of this study was to investigate the effects of oral glycine administration on e...
Saved in:
Published in: | Psychiatry and clinical neurosciences 2011-03, Vol.65 (2), p.142-149 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aim: Glycine, one of the non‐essential amino acids, has been reported to be effective in reducing negative symptoms of schizophrenia. Recently, we found that glycine improves subjective sleep quality in humans. The aim of this study was to investigate the effects of oral glycine administration on endogenous 5‐hydroxytryptamine (5‐HT) and dopamine in the prefrontal cortex (PFC) of living rats.
Methods: Microdialysis probes were inserted stereotaxically into the rat prefrontal cortex. Cortical levels of 5‐HT and dopamine were measured following oral administration of 1 or 2 g/kg glycine, 2 g/kg d‐serine, or 2 g/kg L‐serine.
Results: Both glycine and d‐serine significantly increased extracellular 5‐HT levels for 10 min, whereas dopamine levels remained unchanged. L‐serine, in contrast, had no significant effects on 5‐HT levels.
Conclusions: It is possible that the increase in 5‐HT in response to glycine and d‐serine was mediated by N‐methyl‐D‐aspartate receptors. The transient increase in 5‐HT in the PFC might be associated with the alleviation of negative symptoms in patients with schizophrenia and the amelioration of sleep quality in patients with insomnia. |
---|---|
ISSN: | 1323-1316 1440-1819 |
DOI: | 10.1111/j.1440-1819.2010.02181.x |